Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long Term Follow Up for Patients Who Have Received Allogeneic Stem Cell Transplantation of NiCord®/CordIn™, Umbilical Cord Blood-derived Ex Vivo Expanded Stem and Progenitor Cells

NCT02039557 is registered in ClinicalTrials.gov with Gamida Cell ltd as lead sponsor.

NCT NCT02039557
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02039557 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long Term Follow Up for Patients Who Have Received Allogeneic Stem Cell Transplantation of NiCord®/CordIn™, Umbilical Cord Blood-derived Ex Vivo Expanded Stem and Progenitor Cells
Lead sponsor
Gamida Cell ltd
Phase
Observational
Overall status
Completed
Start date
May 1, 2014
Completion date
June 29, 2023
Enrollment
33 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

patients transplanted with nicord/cordin (omidubicel)